GlaxoSmithKline - Cell & Gene Therapy

SG1 2NY (East of England)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£10,851,089

Jan 17 - Dec 24

FUTURE TARGETED HEALTHCARE MANUFACTURING HUB

EPSRC award to University College London and Nigel Titchener-Hooker

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}